IONIZED AND TOTAL MAGNESIUM LEVELS IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS - RELATIONSHIP WITH CHOLESTEROL AND CYCLOSPORINE LEVELS

被引:27
作者
MARKELL, MS
ALTURA, BT
BARBOUR, RL
ALTURA, BM
机构
[1] SUNY HLTH SCI CTR, DEPT SURG, BROOKLYN, NY 11203 USA
[2] SUNY HLTH SCI CTR, DEPT PHYSIOL, BROOKLYN, NY 11203 USA
[3] SUNY HLTH SCI CTR, DEPT PATHOL, BROOKLYN, NY 11203 USA
关键词
CALCIUM; CHOLESTEROL; CYCLOSPORINE; IONIZED MAGNESIUM; RENAL TRANSPLANTATION;
D O I
10.1042/cs0850315
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Ionized magnesium, measured using a newly developed ion-selective electrode, total magnesium, and ionized and total calcium were evaluated in 39 stable, long-term, cyclosporin-treated renal transplant recipients and compared with those of age-matched, nontransplanted control subjects. Total cholesterol, cyclosporin trough level, serum creatinine, time after-transplant and the ratio of ionized calcium to ionized magnesium were also measured in renal transplant recipients and the relationships between these variables and ionized and total magnesium were evaluated. 2. Renal transplant recipients exhibited marked deficits in ionized magnesium, with a mean value of 0.54 +/- 0.01 mmol/l as compared with 0.61 +/- 0.006 mmol/l for normal control subjects (P less-than-or-equal-to 0.05), with a more moderate deficit in total magnesium. Values for ionized and total calcium did not differ. By stepwise linear multiple regression analysis, ionized magnesium was significantly related to cyclosporin trough level and total cholesterol but not to serum creatinine, time after transplant or the dose of cyclosporin. Ionized magnesium correlated inversely with cyclosporin trough level and directly with total cholesterol. The ratio of ionized calcium to ionized magnesium was elevated in renal transplant recipients when compared with control subjects and correlated positively with the cyclosporin trough level. 3. Deficits in ionized magnesium are common during the late post-transplant period in cyclosporin-treated renal transplant recipients. Ionized magnesium may be a more sensitive clinical parameter than total magnesium in this population, in whom total magnesium may be only mildly decreased in the setting of a severe deficit in ionized magnesium. 4. Ionized magnesium correlates with the cyclosporin level. Renal transplant recipients with high cyclosporin levels demonstrate the most severe deficits in ionized magnesium, and this finding could contribute to cyclosporin-induced hypertension and nephrotoxicity. The direct correlation between ionized magnesium and total cholesterol may result from a 'masked magnesium deficiency', as has been suggested in animal models, and requires further study. 5. Accelerated atherosclerosis observed after renal transplantation may relate to alterations in ionized magnesium and elevated ratios of ionized calcium to ionized magnesium, which are associated with atherogenesis in other models.
引用
收藏
页码:315 / 318
页数:4
相关论文
共 18 条
[1]  
ALTURA BM, 1988, MAGNESIUM, V7, P57
[2]  
ALTURA BT, 1992, METHOD FIND EXP CLIN, V14, P297
[3]   MAGNESIUM DIETARY-INTAKE MODULATES BLOOD LIPID-LEVELS AND ATHEROGENESIS [J].
ALTURA, BT ;
BRUST, M ;
BLOOM, S ;
BARBOUR, RL ;
STEMPAK, JG ;
ALTURA, BM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1840-1844
[4]  
BARTON CH, 1989, J LAB CLIN MED, V114, P232
[5]   HYPOMAGNESEMIA AND RENAL MAGNESIUM WASTING IN RENAL-TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORINE [J].
BARTON, CH ;
VAZIRI, ND ;
MARTIN, DC ;
CHOI, S ;
ALIKHANI, S .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (04) :693-699
[6]  
ELIN RJ, 1988, YEARBOOK CHICAGO, V34, P161
[7]   THEOPHYLLINE AND MAGNESIUM INHIBIT THE CONTRACTION ELICITED WITH CICLOSPORIN AND ANGIOTENSIN-II IN MESANGIAL CELL-CULTURES [J].
FANDREY, J ;
ROB, PM ;
JELKMANN, W .
NEPHRON, 1991, 57 (01) :94-98
[8]  
FASSBINDER W, 1987, TRANSPLANT P, V19, P3754
[9]  
HAAGWEBER M, 1990, MINER ELECTROL METAB, V16, P66
[10]   CORRELATION OF HYPOMAGNESEMIA WITH THE ONSET OF CYCLOSPORINE-ASSOCIATED HYPERTENSION IN MARROW TRANSPLANT PATIENTS [J].
JUNE, CH ;
THOMPSON, CB ;
KENNEDY, MS ;
LOUGHRAN, TP ;
DEEG, HJ .
TRANSPLANTATION, 1986, 41 (01) :47-51